SEC Form D · filed January 3, 2023
Neumora Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (20)
Matthew Fust · Watertown, MADirectorPaul Berns · Short Hills, NJExec · DirectorStacie Weninger · Menlo Park, CADirectorJoshua Pinto · Watertown, MAExecMaykin Ho · Watertown, MADirectorKristina Burow · Chicago, ILDirectorRobert Nelsen · Seattle, WADirectorKari Stefansson · Watertown, MADirectorAlaa Halawa · Watertown, MADirectorTamara Tompkins · Emeryville, CAExecKristina Burow · Ann Arbor, MIDirectorMatthew Fust · Watertown, MADirectorRobert Nelsen · Hampton, NJDirectorKari Stefansson · Watertown, MADirectorPaul Berns · Short Hills, NJExec · DirectorStacie Weninger · Palo Alto, CADirectorJoshua Pinto · Watertown, MAExecMaykin Ho · Watertown, MADirectorAlaa Halawa · Watertown, MADirectorTamara Tompkins · Watertown, MAExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗